Cargando…
The ACR20 and defining a threshold for response in rheumatic diseases: too much of a good thing
In the past 20 years great progress has been made in the development of multidimensional outcome measures (such as the Disease Activity Score and ACR20) to evaluate treatments in rheumatoid arthritis, a process disseminated throughout rheumatic diseases. These outcome measures have standardized the...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978644/ https://www.ncbi.nlm.nih.gov/pubmed/24387346 http://dx.doi.org/10.1186/ar4428 |